Related Tags >> Labopharm FDA Phase III Biovail

Tramadol News

Most Popular Tramadol Story

ALSO NOTED: Merck gets OK for new type of HIV drug; Hycamtin is approved; Labopharm appeals FDA decision; and much more...

October 15, 2007 — 5:59am ET

> The FDA has approved Merck's Isentress for HIV. This is a new type of drug, which prevents HIV from inserting its DNA into human DNA, stunting its ability to infect cells. Read more...

Tramadol Press Releases

PRESS RELEASE: Labopharm receives FDA response to appeal of Approvable Letter for once-daily tramadol

Latest Headlines

Labopharm hopes high for tramadol despite rejection
June 30, 2008
Labopharm 'encouraged' by FDA's stance on Tramadol
January 24, 2008
Labopharm to attempt another tramadol appeal
November 21, 2007
ALSO NOTED: Merck gets OK for new type of HIV drug; Hycamtin is approved; Labopharm appeals FDA decision; and much more...
October 15, 2007
FDA endorses demand for new Cipher study
August 13, 2007
ALSO NOTED: Kosan forges deal with Pfizer; Genta cuts staff; and much more...
December 19, 2006
Labopharm shares sink on approvable letter
September 28, 2006
ALSO NOTED: Daiichi Sankyo invests in venture fund; ImaRx sets IPO terms; and much more...
September 7, 2006
ALSO NOTED: Auxilium enrolling patients; Wyeth wins conditional approval; and much more...
June 28, 2006
Labopharm IPO opens on an upbeat note
April 27, 2006
ALSO NOTED: American Oriental buys Guangxi Lingfeng; CombinatoRx touts mid-stage results; and much more...
April 17, 2006
Labopharm touts pivotal Tramadol data
April 11, 2006
FDA approves Cipher's cholesterol-lowering drug
January 12, 2006
Labopharm gets FDA OK to submit once-daily tramadol
November 30, 2005
FDA approves Biovail's tramadol ER
October 23, 2005
Biovail's once-daily Tramadol approved
September 8, 2005
Labopharm inks $170M distribution deal with Purdue Pharma
August 14, 2005

Paid Research Reports

More Research Reports >>